Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism AMPA receptor antagonists(Glutamate receptor ionotropic AMPA antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epilepsy, Reflex | Phase 2 | US | 31 Oct 2018 |
Phase 2 | 8 | placebo+E2082 (Treatment A: Placebo) | vxpjwnjzup(vnfsfvnrvy) = phjktzrmft rrgrxcknri (eoonxgttbk, syaxofxirs - uxxtdqzwwp) View more | - | 28 Sep 2020 | ||
(Treatment B: E2082 2.5 mg) | vxpjwnjzup(vnfsfvnrvy) = mqndjlqthy rrgrxcknri (eoonxgttbk, ysfljuaabz - vcnqeerqbc) View more |